Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!
Learn More
Breast cancer organoid modeling creates 3D cultures of tumor cells that closely mimic actual breast tumors. These organoids provide a more physiologically relevant model than traditional 2D cultures, allowing researchers to study tumor behavior, drug responses, and the tumor microenvironment. Alfa Cytology offers a comprehensive suite of breast cancer organoid modeling services tailored for research and clinical applications.
Breast cancer (BC) is the most common malignant tumor in women, and its incidence rate ranks first among female malignant tumors. Tumor organoids are the concept of combining organoids and tumors, that is, tumor cells form a microstructure similar to human tumors under appropriate culture conditions and highly restore the tissue structure and gene lineage of human tumors, which can maintain tumor heterogeneity. The construction of BC organoids is mainly composed of three elements, namely BC cells, extracellular matrix, and cytokines. BC organoids can not only promote the personalized treatment of cancer patients but also can be used for the screening of new tumor drugs and the study of the process and mechanism of BC development, etc., which has profound and revolutionary significance for the research of BC.
Fig.1 An organoid culture protocol for ex vivo expansion of mammary stem cells isolated from mouse tissue. (Cui J, et. al., 2021)
Alfa Cytology can select appropriate culture conditions and materials according to your needs quickly to establish BC organoid models. Our goal is to facilitate the robust and reproducible growth of organoids. From basement membrane extracts to growth factors and small molecules, we can create ideal organoid culture conditions that reduce experimental variability. The BC organoid model has the characteristics of convenient material collection, short culture cycle, and genetic stability, which can restore the tissue and molecular characteristics of BC cells in vivo to the greatest extent, and reproduce part of the mammary gland function. BC organoid models have both the advantages of genetic manipulation of tumor cell lines and the three-dimensional complex system characteristics of mouse human-derived tumor tissue xenograft models. Therefore, BC organoids have broad application prospects in the occurrence and development of BC, metastasis, and drug resistance mechanisms, related drug screening, individualized treatment, and transformation of research results.
Fig.2 Culture protocol for breast organoids.
Alfa Cytology has many years of experience in constructing BC organoid models. Based on our advanced platform and experienced scientists, we can build customized, cost-effective, high-quality BC organoids to assist you in your BC organoid model research. If you are interested in learning more about our BC organoid services and solutions please contact us. We will give you a professional and competitively priced strategy that suits your needs as quickly as possible.
Reference